Please login to the form below

Not currently logged in
Email:
Password:

Evoke KYNE promotes Dante DelVecchio to senior VP

DelVecchio takes on the role after ten years at Evoke KYNE

Health communications agency Evoke KYNE has announced the promotion of Dante DelVecchio (pictured above) to senior vice president.

Prior to the promotion, DelVecchio has been working at Evoke KYNE as vice president since 2017. In his new role, he will become a member of the firm’s senior management team, and will continue to oversee key client engagements in infectious diseases, vaccines and immuno-oncology.

“During his decade-long tenure with the company, Dante has risen through the ranks to become a strong team leader and trusted client partner, playing an integral role in the growth of our business,” said Stephanie DeViteri, managing director, Philadelphia at Evoke KYNE.

“As part of this new position, Dante will take on a greater role in business development and in driving company thought leadership,” she added.

In addition to DelVecchio’s promotion, Evoke KYNE recently appointed Molly Grodin as vice president, New York. Most recently, Grodin worked as the director of strategic communications for the Population Council, a global non-profit research organisation addressing critical health and development issues.

Evoke KYNE has also made several more recent hires and appointments across different levels and offices, including the appointment of Silje Lier to vice president, social strategy and the promotion of Christy Loringer to vice president.

Article by
Lucy Parsons

19th August 2020

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics